Real-time enrollment status for this chronic inflammatory demyelinating polyneuropathy clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:47 AM UTC
| NCT Number | NCT06858579 |
| Recruiting Status | Recruiting |
| Condition | Chronic Inflammatory Demyelinating Polyneuropathy |
| Phase | Clinical Trial |
| Target Enrollment | 480 participants |
| Active Locations | 26 sites in the US |
| Sponsor | Dianthus Therapeutics |
| Last Updated on CT.gov | February 18, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT06858579 is currently recruiting participants. This clinical trial study for chronic inflammatory demyelinating polyneuropathy is actively seeking new participants at 26 locations across the United States. The study is sponsored by Dianthus Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06858579 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06858579 was last updated 1 week ago (February 18, 2026). HelloStudys verifies this status automatically.